- Home
- GDRX vs CMPX Comparison
GDRX vs CMPX Comparison
Compare GDRX & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDRX
- CMPX
- Stock Information
- Founded
- GDRX 2011
- CMPX 2014
- Country
- GDRX United States
- CMPX United States
- Employees
- GDRX N/A
- CMPX N/A
- Industry
- GDRX Retail: Computer Software & Peripheral Equipment
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- GDRX Technology
- CMPX Health Care
- Exchange
- GDRX Nasdaq
- CMPX Nasdaq
- Market Cap
- GDRX 913.1M
- CMPX 752.4M
- IPO Year
- GDRX 2020
- CMPX N/A
- Fundamental
- Price
- GDRX $2.70
- CMPX $5.11
- Analyst Decision
- GDRX Buy
- CMPX Strong Buy
- Analyst Count
- GDRX 10
- CMPX 7
- Target Price
- GDRX $5.48
- CMPX $14.43
- AVG Volume (30 Days)
- GDRX 2.9M
- CMPX 1.9M
- Earning Date
- GDRX 11-04-2025
- CMPX 11-05-2025
- Dividend Yield
- GDRX N/A
- CMPX N/A
- EPS Growth
- GDRX N/A
- CMPX N/A
- EPS
- GDRX 0.09
- CMPX N/A
- Revenue
- GDRX $800,651,000.00
- CMPX N/A
- Revenue This Year
- GDRX $2.72
- CMPX N/A
- Revenue Next Year
- GDRX $5.30
- CMPX N/A
- P/E Ratio
- GDRX $31.33
- CMPX N/A
- Revenue Growth
- GDRX 1.30
- CMPX N/A
- 52 Week Low
- GDRX $2.61
- CMPX $1.33
- 52 Week High
- GDRX $5.81
- CMPX $5.11
- Technical
- Relative Strength Index (RSI)
- GDRX 28.52
- CMPX 72.10
- Support Level
- GDRX $2.96
- CMPX $4.79
- Resistance Level
- GDRX $3.05
- CMPX $5.11
- Average True Range (ATR)
- GDRX 0.15
- CMPX 0.32
- MACD
- GDRX -0.01
- CMPX 0.05
- Stochastic Oscillator
- GDRX 14.21
- CMPX 99.70
About GDRX GoodRx Holdings Inc.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.